Discover biologics binders
Clone generation from either hybridoma, phage display or from B cell generates thousands of potential leads. Screening for a primary selection of optimal leads is usually done with an ELISA based Protein-Protein Interaction.
The hits or compounds with the strongest affinity to the target of interest are picked and follow-up screening is performed in various functional assays to determine the biologic candidate’s therapeutic potential.
To help you succeed during this process we offer multiple chemistries for high throughput antigen-protein elucidation. Couple this with our integrated automation solutions we can help save you time and move you quickly toward your lead discovery workflows.
For research use only. Not for use in diagnostic procedures.
